Related Experiment Video
Updated: Mar 12, 2026

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
Published on: July 24, 2019
Clinical Research Informatics for Big Data and Precision Medicine
1Chunhua Weng, PhD, FACMI, Department of Biomedical Informatics, Columbia University, 622 W 168 Street, PH-20, New York, NY 10032, USA,
Clinical Research Informatics (CRI) saw major growth in 2015 with electronic health records and data networks. Persistent challenges include data quality, access, and sustainability.
Area of Science:
- Clinical Research Informatics (CRI)
- Health Informatics
- Biomedical Data Science
Background:
- The year 2015 marked significant advancements and evolving trends within Clinical Research Informatics (CRI).
- Understanding these developments is crucial for navigating the future of clinical research.
Purpose of the Study:
- To review key events and developments in CRI during 2015.
- To identify and discuss emerging trends impacting CRI in the near future.
Main Methods:
- Selection of key publications and scientific community discussions from 2015.
- Consultation of an online living textbook for modern clinical trials.
- Relating new concepts to existing challenges for research continuity.
Main Results:
- Key 2015 highlights include increased adoption of electronic health records (EHR) and the development of clinical data research networks.
- These networks aim to integrate clinical research with care using EHR data for evidence generation.
- Persistent challenges in CRI involve data quality, integration, access, transparency, reproducibility, and infrastructure sustainability.
Conclusions:
- Big Data Analytics and Internet technologies are transforming global clinical research.
- Increased citizen engagement in science is also a key driver.
- The clinical research landscape is becoming more open and stakeholder-centered, involving patients, clinicians, researchers, and sponsors.
Related Concept Videos
Statistical Software for Data Analysis and Clinical Trials
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Overview of Biostatistics in Health Sciences
Biostatistics: Overview
Discrete variables are...
Pharmacogenomics: Identification of New Drug Targets

